Release Date: 14/03/13 09:40 Summary: Non Renounceable Rights Issue Price Sensitive: Yes Download Document 158.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%